Private companies are becoming more and more invested in entering the space race. That means smaller missions - with more freedom in what they can study and explore - could completely change our understanding of the universe. Plus, democrats are changing up their voting strategy. And, Johnson & Johnson has reached another vaccine trial milestone. Guests: Axios' Miriam Kramer, Alexi McCammond, and Caitlin OwensCredits: "Axios Today" is produced in partnership with Pushkin Industries. The team includes Niala Boodhoo, Carol Alderman, Cara Shillenn, Nuria Marquez Martinez, Sara Kehaulani Goo, Alex Sugiura and Naomi Shavin. Music is composed by Evan Viola. You can reach us at podcasts@axios.com.Go deeper: Planetary science in the private space age Democrats' mail voting pivot Johnson & Johnson begins large phase 3 trial of a coronavirus vaccine